EVRAZ appointed Irina Bakhturina to the role of director of Investor Relations effective 5 March 2015. Bakhturina will report to the company’s CFO Pavel Tatyanin. She will assume responsibilities for liaison with investors and analysts as well as for developing and implementing company’s investment strategy together with EVRAZ top-management.
Bakhturina joins EVRAZ from Pharmstandard, the Russian pharmaceutical major, where she was the head of Investor Relations for the last two years. Irina spent her early career in corporate finance and investment banking working at UBS Investment Bank and several other Russian investment companies.
